Back to Results
First PageMeta Content
Motor neurone disease / Neurological disorders / Gross pathology / Rare diseases / Spinal and bulbar muscular atrophy / Muscular system / Amyotrophic lateral sclerosis / Muscular dystrophy / Androgen receptor / Anatomy / Health / Biology


  Contact: Dr. Sapan Shah CEO, ARMGO Pharma[removed]
Add to Reading List

Document Date: 2013-11-14 10:39:33

Open Document

File Size: 59,66 KB

Share Result on Facebook

City

COARSEGOLD / /

Company

ARMGO Pharma Inc. / /

Currency

cent / /

/

Facility

Columbia University / /

IndustryTerm

treatment for Kennedy's Disease / biopharmaceutical / /

MedicalCondition

fatal Lou Gehrig's Disease / Kennedy’s Disease / disease / skeletal muscle diseases / chronic muscle weakness / neurological disorders / skeletal muscle disease / ALS / Duchenne Muscular Dystrophy / muscle weakness / Kennedy's Disease / Spinal Bulbar Muscular Atrophy / heart failure / adult-onset disease / genetic progressive neuromuscular disease / primarily affected causing muscle weakness / /

Organization

Columbia University / Kennedy’s Disease Association / P.O. Box / Kennedy's Disease Association / /

Person

Sapan Shah / Michael Blanar / Lou Gehrig / John A. Coakley / Sr. / /

/

Position

Chief Scientific Officer / CEO / Principal Investigator / Vice President / President and CEO / /

ProvinceOrState

California / /

Technology

RyR technology / /

URL

http /

SocialTag